Merck KGaA is filing for global regulatory approvals of pimicotinib after it met primary and secondary endpoints in a Phase ...

Scynexis has resumed dosing of its Brexafemme (ibrexafungerp) drug in a Phase III trial after a 19-month clinical hold by the ...

The US FDA has granted regenerative medicine advanced therapy (RMAT) designation to AbelZeta Pharma’s C-CAR168.

In the race to decarbonize the global economy, advanced materials are no longer a luxury – they’re a necessity.

PL logistics need to invest in new technology and upskilling programs to scale their cell and gene therapy services.

The US Centers for Disease Control and Prevention (CDC) is no longer recommending Covid-19 vaccines to healthy children and ...

GlycoEra has closed an oversubscribed Series B financing round, raising $130m, to support its lead IgG4-targeted protein ...

Biogen and City Therapeutics are to partner for the development of new RNA interference (RNAi) therapies. Leveraging ...